(1) is disseminated only to members of the medical, dental, pharmaceutical, and other legally recognized professions dealing with the healing arts;

(2) appears only in the scientific periodicals of those professions; or

(3) is disseminated only for the purpose of public health education by persons not commercially interested in the sale of such drugs or devices.

     (b) The advertisement of a drug or device that represents that the drug or device has any effect in:

albuminuria;

appendicitis;

arteriosclerosis;

blood poison;

bone disease;

Bright’s disease;

carbuncles;

cancer;

cholecystitis;

diabetes;

diphtheria;

dropsy;

erysipelas;

gallstones;

heart and vascular diseases;

high blood pressure;

mastoiditis;

measles;

mumps;

nephritis;

otitis media;

paralysis;

pneumonia;

poliomyelitis (infantile paralysis);

prostate gland disorders;

pyelitis;

scarlet fever;

sexual impotence;

sexually transmitted infection;

sinus infection;

smallpox;

tuberculosis;

tumors;

typhoid;

uremia; or

meningitis;

is considered false for purposes of IC 35-43-5-4.

     (c) Whenever the state department determines that an advance in medical science has made a type of self medication safe as to any of the diseases listed in this section, the state department shall adopt rules to authorize the advertisement of drugs having curative or therapeutic effect for the disease, subject to conditions and restrictions the state department considers necessary in the interests of public health.

[Pre-1993 Recodification Citation: 16-1-28-7.]

As added by P.L.2-1993, SEC.25. Amended by P.L.174-2021, SEC.17; P.L.147-2023, SEC.26.